BRAF and metastatic melanoma: After failure of immune checkpoint inhibitors or in patients progressing rapidly after BRAF and MEK inhibitors, chemotherapies, such as carboplatin and paclitaxel (CP), are still used to treat rapidly growing metastatic melanoma.